Sibutramine reduces body weight and does not alter blood pressure control in obese hypertensive patients

被引：0
|
作者：
Faria, AN [1 ]
Ribeiro, FF [1 ]
Lerario, DD [1 ]
Kohlmann, N [1 ]
Ferreira, SRG [1 ]
Ribeiro, AB [1 ]
Zanella, MT [1 ]
机构：
[1] Univ Fed Sao Paulo, Hosp Rim & Hipertens, Sao Paulo, Brazil
来源：
JOURNAL OF HYPERTENSION | 2002年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
P862
引用
收藏
页码：S208 / S208
页数：1
相关论文
共 50 条
  • [21] EFFECTS OF WEIGHT-LOSS ON BLOOD-PRESSURE IN MASSIVELY OBESE HYPERTENSIVE PATIENTS
    VERTES, V
    MILLER, SA
    DORNFELD, L
    PREVENTIVE MEDICINE, 1979, 8 (02) : 243 - 243
  • [22] Influence of sibutramine on blood pressure: Evidence from two placebo-controlled trials with hypertensive obese patients in Germany
    Jordan, J
    Scholze, J
    Matiba, B
    Wirth, A
    Hauner, H
    Sharma, AM
    INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 : S138 - S138
  • [23] Sibutramine enhancing the glucose profile on hypertensive obese patients
    Faria, A
    Lerário, D
    Kholmann, N
    Ferreira, SRG
    Zanella, MT
    OBESITY RESEARCH, 2001, 9 : 197S - 197S
  • [24] Sibutramine plus meal replacement therapy for body weight loss and maintenance in obese patients
    Early, James L.
    Apovian, Caroline M.
    Aronne, Louis J.
    Fernstrom, Madelyn H.
    Frank, Arthur
    Greenway, Frank L.
    Heber, David
    Kushner, Robert F.
    Cwik, Kristine M.
    Walch, Julia K.
    Hewkin, Ann C.
    Blakesley, Vicky
    OBESITY, 2007, 15 (06) : 1464 - 1472
  • [25] Meta-analysis of blood pressure in obese patients treated with sibutramine for weight loss shows mean changes are small
    Astrup, A
    Wickens, M
    OBESITY RESEARCH, 2000, 8 : 83S - 83S
  • [26] Six-week treatment period with sibutramine reduces blood pressure in high-risk hypertensive patients - An analysis of the sibutramine cardiovascular outcomes (SCOUT) trial
    Sharma, Arya
    Caterson, Ian
    Coutinho, Walmir
    Finer, Nick
    Van Gaal, Luc
    Maggioni, Aldo
    Torp-Pedersen, Christian
    James, W. Philip T.
    INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 : S168 - S168
  • [27] Six-week treatment period with sibutramine reduces blood pressure in high-risk hypertensive patients - An analysis of the sibutramine cardiovascular outcomes ( SCOUT) trial
    Sharma, Arya M.
    Caterson, Ian
    Coutinho, Walmir
    Finer, Nick
    Van Gaal, Luc
    Maggioni, Aldo P.
    Torp-Pedersen, Christian
    James, W. Philip T.
    INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 (09) : 1490 - 1490
  • [28] Effect of body weight loss on blood pressure in stage 1 hypertensive overweight patients
    Fogari, Roberto
    Preti, Paola
    Lazzari, Pierangelo
    Zoppi, Annalisa
    Fogari, Elena
    Destro, Maurizio
    Rinaldi, Andrea
    Mugellini, Amedeo
    HYPERTENSION, 2007, 50 (04) : E136 - E136
  • [29] Relationship between blood pressure: And body weight composition in overweight-obese patients
    Cipollini, F
    Breschi, C
    Arcangeli, E
    Tesi, F
    Fabbri, G
    Malagoli, R
    Piluso, A
    Seghieri, G
    JOURNAL OF HYPERTENSION, 2005, 23 : S335 - S335
  • [30] IS IT DEXFENFLURAMINE OR WEIGHT-LOSS THAT REDUCES BLOOD-PRESSURE AND NORADRENERGIC ACTIVITY IN OBESE PATIENTS
    BERLIN, I
    PUECH, AJ
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 44 (06) : 601 - 601
12345